Results 261 to 270 of about 179,392 (293)

Angiotensin Converting Enzyme Inhibitors

1999
The synthesis of the first orally active angiotensin converting enzyme (ACE) inhibitor in the 1977, heralded one of the major therapeutic advances of the last decades. Initially designed to be a pathophysiological meaningful tool for the treatment of severe malignant hypertension, ACE inhibitors are now widely accepted as first line approach to the ...
openaire   +1 more source

Inhibitors of Angiotensin-Converting Enzyme

1980
D W, Cushman, M A, Ondetti, H S, Cheung, M J, Antonaccio, V S, Murthy, B, Rubin   +5 more
openaire   +2 more sources

Angiotensin-converting enzyme inhibitors

Journal of the American Academy of Dermatology, 1993
Anil Abraham, Eugene Farber
openaire   +2 more sources

Angiotensin converting enzyme Inhibitors

American Heart Journal, 1989
Robert A. Scott, David B. Barnett
  +5 more sources

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

Lancet, The, 2003
Christopher B Granger, Salim Yusuf, Jan Östergren   +2 more
exaly  

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

Lancet, The, 2003
Jan Östergren, Karl Swedberg, Christopher B Granger   +2 more
exaly  

Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study

Lancet, The, 2002
Graziano Onder, Rajesh Balkrishnan, Linda P Fried   +2 more
exaly  

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study

Lancet, The, 2003
Stefan D Anker, Salim Yusuf, Andrew Coats   +2 more
exaly  

Angiotensin-Converting Enzyme Inhibitors

2007
Alan H. Gradman, Darren Traub
openaire   +2 more sources

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

Lancet, The, 2006
Gilles R Dagenais, Janice Pogue, Salim Yusuf   +2 more
exaly